Hemorrhagic Shock Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 6 studies associated with Hemorrhagic Shock.
Here is a small sampling of Hemorrhagic Shock studies by title:
- Cannabidiol alleviates hemorrhagic shock-induced neural apoptosis in rats by inducing autophagy through activation of the PI3K/AKT pathway
- Pharmacokinetics of a Combination of Δ9-tetrahydro-cannabinol and Celecoxib in a Porcine Model of Hemorrhagic Shock
- Low-volume Binary Drug Therapy for the Treatment of Hypovolemia
- CB1 cannabinoid receptor participates in the vascular hyporeactivity resulting from hemorrhagic shock in rats
- Cannabinoid CB(1) receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat
Components of the Hemorrhagic Shock Research Dashboard
- Dosing information available for Hemorrhagic Shock
- Chemotype guidance for treating Hemorrhagic Shock with cannabis
- Synopsis of cannabis research for Hemorrhagic Shock
- Individual study details for Hemorrhagic Shock
Ready to become a subscriber? Go to our PRICING page.
Select New Condition
Search By Keyword
Overview - Hemorrhagic Shock
Description of Hemorrhagic Shock
Hemorrhagic shock is defined as inadequate tissue perfusion due to blood loss. The bodies tissue are not receiving their essential supplies of oxygen and other nutrients needed for survival. It is a medical emergency the degree of which is determined by the actual amount of blood lost. In basic terms without an adequate blood supply the heart and vascular systems are rendered ineffective and shock occurs by the impairment of cellular respiration and metabolism. Causes include traumatic events and a resulting loss of blood. If not immediately treated the body shuts down the periphery first (arms, legs) to direct the few remaining fluids to essential organs especially the heart, lungs and the brain.Disease Classification
Condition: Hemorrhagic ShockDisease Family:
Organ System: Cardiovascular System
ICD-10 Chapter: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 Code: R57.8
Hemorrhagic Shock Symptoms:
Confusion, pale and clammy skin, confusion, hypotension, tachycardiaAlso known as:
Hypovolemic ShockDrug Interactions
THC Interaction with Pharmaceutical Drugs
- THC can enhance the effects of drugs that cause sedation and depress the central nervous system, such as benzodiazepines, barbiturates, and alcohol, for example.
- THC is metabolized by and an inhibitor of a number of enzymatic liver pathways referred to as cytochrome P450. There are more than 50 enzymes belonging to this enzyme family, a number of which are responsible for the breakdown of common drugs such as antidepressants (e.g. amitriptyline, doxepine, fluvoxamine), antipsychotics (haloperidol, clozapine, stelazine), beta-blockers (e.g. propranolol), bronchodilators (e.g. theophylline), or bloodthinners (e.g. warfarin). Thus patients taking these classes of medication may find that THC increases the concentration and effects of these drugs as well as the duration of their effects.
- Clinical observation suggests no likely interactions with other pharmaceuticals at a total daily dose of up to 20mg THC.
CBD Interaction with Pharmaceutical Drugs
- CBD may alter action on metabolic enzymes (certain drug-transport mechanisms), and as such may alter interactions with other drugs, some of which may produce therapeutic or adverse effects. For instance, CBD interacts with the enzyme cytochrome P450 3A4 and cytochrome P450 2C19, increasing the bioavailability of anti-epileptic drugs such as clobazam (a benzodiazepine). This makes it possible to achieve the same results at significantly lower dosages, reducing treatment costs and risks of adverse effects.
- Groups of drugs affected include: anti-epileptic drugs, psychiatric drugs, and drugs affecting metabolic enzymes, for example.
- Clinical observations suggest no likely interactions with other pharmaceuticals at a total daily dose of up to 100mg CBD
Dosing Considerations
THC Dosage Considerations
- THC micro dose: 0.1 mg to 0.4 mg
- THC low dose: 0.5 mg to 5 mg
- THC medium dose: 6 mg to 20 mg
- THC high dose: 21 mg to 50+ mg
CBD Dosage Considerations
- CBD low dose: 0.4 mg to 19 mg
- CBD medium dose: 20 mg to 99 mg
- CBD high dose: 100 mg to 800+ mg (upper limits tested ~1,500mg)
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
